Stay updated on Duvelisib for COVID-19 Clinical Trial
Sign up to get notified when there's something new on the Duvelisib for COVID-19 Clinical Trial page.

Latest updates to the Duvelisib for COVID-19 Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe page footer now shows a newer ClinicalTrials.gov UI build/revision number (v3.5.3) instead of the previous one (v3.5.2), indicating an interface/version update rather than a change to the underlying study record.SummaryDifference0.1%

- Check19 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check27 days agoNo Change Detected
- Check48 days agoChange DetectedThe site revision label was updated to v3.5.0, replacing the previous v3.4.3 revision.SummaryDifference0.1%

- Check55 days agoChange DetectedAdded the revision label Revision: v3.4.3 to the page. Removed the previous revision label Revision: v3.4.2.SummaryDifference0.1%

- Check84 days agoChange DetectedRevision: v3.4.2 was added and v3.4.1 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check91 days agoChange DetectedRevision: v3.4.0 was removed and v3.4.1 added, a minor software update with no changes to study content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Duvelisib for COVID-19 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Duvelisib for COVID-19 Clinical Trial page.